Article
The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells.
Oncogene - 26 Mar 1998
Zhang C C, Yang J M, White E, Murphy M, Levine A, Hait W N
Abstract excerpt
Mutations in p53 change the sensitivity to cancer chemotherapeutic drugs. Whereas many drugs, including the vinca alkaloids, often become less effective when p53 is transcriptionally inactivated, several, most notably paclitaxel, may become more effective. In studying the underlying mechanism(s),...
Topics
- 3T3 Cells
- Animals
- Antineoplastic Agents
- Cell Cycle
- Cell Line
- Drug Resistance, Multiple
- Kidney
- Mice
- Mice, Inbred BALB C
- Microtubule-Associated Proteins
- Microtubules
- Mutation
- Paclitaxel
- Polymers
- Rats
- Receptors, Drug
- Tumor Suppressor Protein p53
- Vinblastine